It has been reported that after sciatic nerve ligation, a CCR5 antagonist simultaneously prevented pain-related behavior development and glia activation while also enhancing the efficacy of morphine (22); however, in diabetic neuropathy was not as effective. This evidence concerns the gene CCR5 and diabetic neuropathy.